Approved by the U.S. Food and Drug Administration in 1994, Lamictal (lamotrigine) is used to treat patients who suffer from epilepsy. Specifically, the drug is used to control the occurrence of partial seizures, primary and secondary tonic-clonic seizures and the symptoms of Lennox-Gastaut syndrome. In 2003, the FDA also approved Lamictal for treatment of bipolar disorder.